135 related articles for article (PubMed ID: 35526388)
1. Establishment of human embryonic stem cell WAe009-A-88 carrying a long QT syndrome mutation in KCNH2.
Wen H; Sun L; Zhong J; Wu F
Stem Cell Res; 2022 Jul; 62():102795. PubMed ID: 35526388
[TBL] [Abstract][Full Text] [Related]
2. Establishment of human embryonic stem cell WAe009-A-74 carrying a Long QT syndrome mutation in KCNH2.
Sun L; Zhong J; Wu F; Li F; Yang X; Zeng Z
Stem Cell Res; 2022 Apr; 60():102725. PubMed ID: 35247842
[TBL] [Abstract][Full Text] [Related]
3. Generation of a human embryonic stem cell line (WAe009-A-43) carrying a Long QT syndrome related mutation in KCNH2 gene.
Wu X; Zhao Y; Wang X
Stem Cell Res; 2020 Oct; 48():101976. PubMed ID: 32911324
[TBL] [Abstract][Full Text] [Related]
4. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
Mondéjar-Parreño G; Jahng JWS; Belbachir N; Wu BC; Zhang X; Perez MV; Badhwar N; Wu JC
Stem Cell Res; 2021 Jul; 54():102402. PubMed ID: 34051449
[TBL] [Abstract][Full Text] [Related]
5. Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant.
Zhao J; Wang L; Zhu K; Chen X; Qin F; Li X; Dong J; Tao H
Stem Cell Res; 2022 Aug; 63():102836. PubMed ID: 35700634
[TBL] [Abstract][Full Text] [Related]
6. Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation.
Guo F; Sun Y; Wang H; Wang H; Zhou J; Fan H; Su J; Gong T; Jiang C; Liang P
Stem Cell Res; 2022 Jul; 62():102813. PubMed ID: 35569348
[TBL] [Abstract][Full Text] [Related]
7. Establishment of human embryonic stem cell WAe009-A-48 carrying a long QT syndrome mutation in SCN5A.
Yang X; Wu F; Zhong J; Li F
Stem Cell Res; 2021 Mar; 51():102194. PubMed ID: 33517120
[TBL] [Abstract][Full Text] [Related]
8. Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.
Goual L; Bounasri E; Vincenti M; Amédro P; Desprat R; Bernex F; Lemaitre JM; Pasquié JL; Lacampagne A; Thireau J; Meli AC
Stem Cell Res; 2023 Oct; 72():103192. PubMed ID: 37660555
[TBL] [Abstract][Full Text] [Related]
9. Generation of a human embryonic stem cell line WAe009-A-79 carrying a long QT syndrome mutation in KCNQ1.
Wang H; Guo T; Lan F
Stem Cell Res; 2023 Aug; 70():103119. PubMed ID: 37244124
[TBL] [Abstract][Full Text] [Related]
10. The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.
Mura M; Mehta A; Ramachandra CJ; Zappatore R; Pisano F; Ciuffreda MC; Barbaccia V; Crotti L; Schwartz PJ; Shim W; Gnecchi M
Int J Cardiol; 2017 Aug; 240():367-371. PubMed ID: 28433559
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant.
Ge N; Liu M; Krawczyk J; McInerney V; Ward D; Shen S; O'Brien T; Prendiville T
Stem Cell Res; 2020 Dec; 49():101997. PubMed ID: 33002718
[TBL] [Abstract][Full Text] [Related]
12. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.
O'Hare BJ; John Kim CS; Hamrick SK; Ye D; Tester DJ; Ackerman MJ
Circ Genom Precis Med; 2020 Oct; 13(5):466-475. PubMed ID: 32940533
[TBL] [Abstract][Full Text] [Related]
13. Derivation and characterization of two human induced pluripotent stem cell lines (NUIGi004-A) and (NUIGi012-A) from two patients with LQT2 disease.
Liu M; Ge N; Zhang J; Yang M; Yang F; Krawczyk J; Ward D; McInerney V; O'Brien T; Shen S; Prendiville T
Stem Cell Res; 2021 Oct; 56():102555. PubMed ID: 34628246
[TBL] [Abstract][Full Text] [Related]
14. Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2
Ono M; Burgess DE; Schroder EA; Elayi CS; Anderson CL; January CT; Sun B; Immadisetty K; Kekenes-Huskey PM; Delisle BP
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32759882
[TBL] [Abstract][Full Text] [Related]
15. Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome).
Wang B; Ren Q; Cui X; Shan W; Guo X; Wang X; Wang J; Li Y; An G
Stem Cell Res; 2024 Jun; 77():103400. PubMed ID: 38547667
[TBL] [Abstract][Full Text] [Related]
16. Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2.
Fatima A; Ivanyuk D; Herms S; Heilmann-Heimbach S; O'Shea O; Chapman C; Izsvák Z; Farr M; Hescheler J; Šarić T
Stem Cell Res; 2016 Mar; 16(2):304-7. PubMed ID: 27345990
[TBL] [Abstract][Full Text] [Related]
17. The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome.
Cai D; Zheng Z; Jin X; Fu Y; Cen L; Ye J; Song Y; Lian J
J Cardiovasc Transl Res; 2023 Feb; 16(1):209-220. PubMed ID: 35976484
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a human-induced pluripotent stem cell line, KSCBi014-A, from a long QT syndrome type 2 patient harboring a KCNH2 mutation.
Lee Y; Koo SK; Kim JH
Stem Cell Res; 2021 Dec; 57():102570. PubMed ID: 34678663
[TBL] [Abstract][Full Text] [Related]
19. Targeted next generation sequencing revealed a novel deletion-frameshift mutation of KCNH2 gene in a Chinese Han family with long QT syndrome: A case report and review of Chinese cases.
Du F; Wang G; Wang D; Su G; Yao G; Zhang W; Su G
Medicine (Baltimore); 2020 Apr; 99(16):e19749. PubMed ID: 32311972
[TBL] [Abstract][Full Text] [Related]
20. A Novel Mutation in the KCNH2 Gene Associatedwith Long QT Syndrome: A Case Report.
Zha K; Ye Q
Ann Clin Lab Sci; 2021 Mar; 51(2):258-261. PubMed ID: 33941567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
